Form D · Other Health Care
Avantis Medical Systems Inc
San Jose, CA · CIK 0001325768
Offering snapshot reported Mar 19, 2018 · SEC filing
- Reported sold
- $2.29M Offering amount: $2.5M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 28, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 19, 2018 | Initial | $2,289,201 | No comparison | 4 | SEC filing |
| Apr 25, 2017 | Initial | $534,000 | No comparison | 1 | SEC filing |
| Aug 17, 2016 | Initial | $1,005,185 | No comparison | 19 | SEC filing |
| Aug 17, 2016 | Initial | $1,843,316 | No comparison | 8 | SEC filing |
| Aug 17, 2016 | Initial | $2,000,000 | No comparison | 1 | SEC filing |
| Aug 17, 2016 | Initial | $2,000,000 | No comparison | 1 | SEC filing |
| Aug 17, 2016 | Amendment | $10,312,330 | $9,066,660vs Mar 8, 2013 | 23 | SEC filing |
| Jan 15, 2014 | Amendment | $4,846,773 | $1,798,305vs Jul 25, 2013 | 6 | SEC filing |
| Jul 25, 2013 | Amendment | $3,048,468 | $695,670vs May 23, 2013 | 6 | SEC filing |
| May 23, 2013 | Amendment | $2,352,798 | $1,107,128vs Mar 8, 2013 | 6 | SEC filing |
| Mar 8, 2013 | Initial | $1,245,670 | No comparison | 2 | SEC filing |
| Apr 23, 2012 | Initial | $800,080 | No comparison | 1 | SEC filing |
| Oct 12, 2011 | Initial | $150,000 | No comparison | 1 | SEC filing |
| Jul 8, 2011 | Initial | $17,876,583 | No comparison | 40 | SEC filing |
| May 12, 2011 | Initial | $2,210,665 | No comparison | 9 | SEC filing |
| Feb 15, 2011 | Amendment | $2,255,244 | $755,094vs Nov 23, 2010 | 7 | SEC filing |
| Nov 23, 2010 | Initial | $1,500,150 | No comparison | 7 | SEC filing |
| Aug 26, 2010 | Amendment | $2,814,349 | $683,150vs Jun 9, 2010 | 21 | SEC filing |
| Jun 9, 2010 | Initial | $2,131,199 | No comparison | 12 | SEC filing |
| Dec 17, 2009 | Initial | $1,436,411 | No comparison | 2 | SEC filing |
| Sep 3, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 15, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 8, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 30, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 27, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-307985
Source: Form D, filed Mar 19, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Anthony Di Tonno | Director, Executive |
| Scott Dodson | Director, Executive |
| Phil English | Director |
| Thomas J. Fogarty | Director |
| Daniel George | Executive |
| Salman Hameed | Executive |
| John H. Higgins | Executive |
| Matthew Jenusaitis | Director |
| Joe Kure | Director |
| Michael Mayer | Director |
| Camran Nazhat | Director |
| Camran Neshat | Director |
| Camran Nezhat | Director |
| Howard Palefsky | Director |
| Richard Randall | Director, Executive |
| John Reed | Executive |
| John Savarese | Director |
| Fred R. Seddiqui | Director |
| David Silverman | Director |
| Mark Ten Boer | Executive |
| Daniel Turner Iii | Director |
| Robert Wah | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2367 Bering Drive
San Jose, CA, 95131
San Jose, CA, 95131